Case study in cardiovascular medicine

Network Meta-Analysis: Evidence Synthesis with Mixed Treatment Comparison

Volumn , Issue , 2014, Pages 285-306

  He, Yulei ^a   Bittl, John A ^b   Wouhib, Abera ^a   Normand, Sharon Lise T ^c,d  

^a NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^b Munroe Regional Med Center   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Bayesian decision making; bypass; coronary artery disease; cross desig synthesis; historical data; prior distribution; sensitivity analysis; stent

Indexed keywords

EID: 84940955943     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (47)

1. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat in Med 2002; 21: 2313-24.
2. Prevost TC, Abrams KR, Jones DR. Hierarchical models in generalized synthesis of evidence: an example based on studies of breast cancer screening. Stat in Med 2000; 19: 3359-76.
3. Huang HW, Brent BN, Shaw RE. Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era: a report from the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). Catheter Cardiovasc Interv 2006; 68: 867-72.
4. Kappetein AP, Dawkins KD, Mohr FW, Morice MC, Mack MJ, Russell ME, Pomar J, Serruys PW. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase. Eur. J. Cardiothorac Surg 2006; 29: 486-91.
5. Conley MJ, Ely RL, Kisslo J, Lee KL, McNeer JF, Rosati RA. The prognostic spectrum of left main stenosis. Circulation 1978; 57: 947-52.
6. Takaro T, Peduzzi P, Detre KM, Hultgren HN, Murphy ML, van der Bel-Kahn J, Thomsen J, Meadows WR. Survival in subgroups of patients with left main coronary artery disease. Veterans Administration Cooperative Study of Surgery for Coronary Arterial Occlusive Disease. Circulation 1982; 66: 14-22.
7. Chaitman BR, Fisher LD, Bourassa MG, Davis K, Rogers WJ, Maynard C, Tyras DH, Berger RL, Judkins MP, Ringqvist I, Mock MB, Killip T. Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the Collaborative Study in Coronary Artery Surgery (CASS). Am. J. Cardiol 1981; 48: 765-77.
8. Oberman A, Kouchoukos NT, Harrell RR, Holt JH Jr, Russell ROJ, Rackley CE. Surgical versus medical treatment in disease of left main coronary artery. Lancet 1976; 2: 591-4.
9. Cohen MV, Gorlin R. Main left coronary artery disease: clinical experience from 1964-1974. Circulation 1975; 52: 275-85.
10. Talano JV, Scanlon PJ, Meadows WR, Kahn M, Pifarre R, Gunnar RM. Influence of surgery on survival in 145 patients with left main coronary artery disease. Circulation 1975; 51(suppl I): 105-11.
11. European Coronary Surgery Study Group. Long term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris. Lancet 1982; 2: 1173-80.
12. Dzavik V, Ghali WA, Norris C, Mitchell LB, Koshal A, Saunders LD, Galbraith PD, Hui W, Faris P, Knudtson ML; Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators. Long-term survival in 11, 661 patients with multivessel coronary artery disease in the era of stenting: a report from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators. Am. Heart J. 2001; 142: 119-26.
13. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, Davis K, Killip T, Passamani E, Norris R. Effect of coronary artery bypass surgery on survival: overview of 10-year results from randomised trials by Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994; 344: 563-70.
14. Morice MC, Serruys PW, Kappetein AP, Feldman TE, Stahle E, Colombo A, Mack MJ, Holmes DR, Torracca L, van Es GA, Leadley K, Dawkins KD, Mohr F. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 2010; 121: 2645-53.
15. Buszman PE, Kiesz SR, Bochenek A, Peszek-Przybyla E, Szkrobka I, Debinski M, Bialkowska B, Dudek D, Gruszka A, Zurakowski A, Milewski K, Wilczynski M, Rzeszutko L, Buszman P, Szymszal J, Martin JL, Tendera M. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J. Am. Coll Cardiol. 2008; 51: 538-45.
16. Boudriot E, Thiele H, Walther T, Liebetrau C, Boeckstegers P, Pohl T, Reichart B, Mudra H, Beier F, Gansera B, Neumann FJ, Gick M, Zietak T, Desch S, Schuler G, Mohr FW. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. J. Am. Coll Cardiol 2011; 57: 538-45.
17. Park SJ, Kim YH, Park DW, Yun SC, Ahn JM, Song HG, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Park SW, Chung CH, Lee JW, Lim DS, Rha SW, Lee SG, Gwon HC, Kim HS, Chae IH, Jang Y, Jeong MH, Tahk SJ, Seung KB. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N. Engl J. Med. 2011; 364: 1718-27.
18. White AJ, Kedia G, Mirocha JM, Lee MS, Forrester JS, Morales WC, Dohad S, Kar S, Czer LS, Fontana GP, Trento A, Shah PK, Makkar RR. Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis. J. Am. Coll CardiolIntv. 2008; 1: 236-45.
19. Seung KB, Park DW, Kim YH, Lee SW, Lee CW, Hong MK, Park SW, Yun SC, Gwon HC, Jeong MH, Jang Y, Kim HS, Kim PJ, Seong IW, Park HS, Ahn T, Chae IH, Tahk SJ, Chung WS, Park SJ. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl. J. Med. 2008; 358: 1781-92.
20. Wu C, Hannan EL, Walford G, Faxon DP. Utilization and outcomes of unprotected left main coronary artery stenting and coronary artery bypass graft surgery. Ann. Thorac Surg. 2008; 86: 1153-9.
21. Brener SJ, Galla JM, Bryant R, 3rd, Sabik JF, 3rd, Ellis SG. Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients. Am. J. Cardiol. 2008; 101: 169-72.
22. Chieffo A, Morici N, Maisano F, Bonizzoni E, Cosgrave J, Montorfano M, Airoldi F, Carlino M, Michev I, Melzi G, Sangiorgi G, Alfieri O, Colombo A. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation 2006; 113: 2542-7.
23. Mäkikallio TH, Niemelä M, Kervinen K, Jokinen V, Laukkanen J, Ylitalo I, Tulppo MP, Juvonen J, Huikuri HV. Coronary angioplasty in drug eluting stent era for the treatment of unprotected left main stenosis compared to coronary artery bypass grafting. Ann. Med. 2008; 40: 437-43.
24. Palmerini T, Marzocchi A, Marrozzini C, Ortolani P, Saia F, Savini C, Bacchi-Reggiani L, Gianstefani S, Virzi S, Manara F, Kiros Weldeab M, Marinelli G, Di Bartolomeo R, Branzi A. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry). Am. J. Cardiol. 2006; 98: 54-9.
25. Sanmartín M, Baz JA, Claro R, Asorey V, Durán D, Pradas G, Iñiguez A. Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease. Am. J. Cardiol. 2007; 100: 970-3.
26. Bittl JA, He Y, Jacobs AK, Yancy CW, Normand S-LT. Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease. Circulation 2013; 127: 2177-85.
27. Gelman A, Carlin JB, Stern HS, Rubin DB. Bayesian Data Analysis. Chatfield C, Tanner M, Zidek J, editors. Boca Raton, FL: Chapman and Hall/CRC; 2013.
28. Agresti A. Categorical Data Analysis. New York: Wiley; 1990.
29. Normand S-LT. Tutorial in biostatistics: Meta-analysis: Formulating, evaluating, combining and reporting. Stat in Med. 1999; 18: 321-59.
30. Higgins JPT, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. JR Stat Soc Ser A Stat Soc. 2009; 172: 137-59.
31. Gelman AE, Carlin JB, Stern HS, Rubin DB. Bayesian Data Analysis. London: Chapman and Hall; 2004.
32. Armitage P, Berry G, Matthews JNS. Clinical trials. Statistical Methods in Clinical Research. Malden, MA: Blackwell Science; 2002; 591-647.
33. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
34. Gelfand AE, Smith AFM. Sampling-based approaches to calculate marginal densities. J. Am Stat Assoc. 1990; 85: 398-409.
35. Gelman A, Rubin DB. Inference from iterative simulation using multiple sequences. Stat Sci 1992; 7: 457-72.
36. Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian Approaches to Clinical Trials and Health Care Evaluations. Chichester, England: Wiley; 2004.
37. Light RJ, Pillemer DB. Summing Up: The Science of Reviewing Research. Cambridge, MA: Harvard University Press; 1984.
38. Jacobs AK, Kushner FG, Ettinger SM, Guyton RA, Anderson JL, Ohman EM, Albert NM, Antman EM, Arnett DK, Bertolet M, Bhatt DL, Brindis RG, Creager MA, DeMets DL, Dickersin K, Fonarow GC, Gibbons RJ, Halperin JL, Hochman JS, Koster MA, Normand SL, Ortiz E, Peterson ED, Roach WH Jr, Sacco RL, Smith SC Jr, Stevenson WG, Tomaselli GF, Yancy CW, Zoghbi WA, Harold JG, He Y, Mangu PB, Qaseem A, Sayre MR, Somerfield MR. ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll Cardiol. 2012; 61: 213-65.
39. nd ed. New York: Springer-Verlag; 2002.
40. Peters JL, Rushton L, Sutton AJ, Jones DR, Abrams KR, Mugglestone MA. Bayesian methods for the cross-design synthesis of epidemiological and toxocological evidence. Appl Stat 2005; 54: 159-72.
41. Greenland S. A critical look at some popular meta-analytical methods. Am. J. Epidemiol 1994; 140: 290-6.
42. Bittl JA, He Y, Jacobs AK, Yancy CW, Normand S-LT. Response to two letters. Circulation 2014 - in press.
43. Berger JO. Statistical Decision Theory and Bayesian Analysis. New York: SpringerVerlag; 1980.
44. Diamond GA, Kaul S. Bayesian classification of clinical practice guidelines. Arch Intern Med 2009; 169: 1431-5.
45. Goodman SN. Bayesian methods for evidence evaluation: are we there yet? Circulation 2013; 127: 2367-9.
46. Palmerini T, Marzocchi A, Tamburino C, Sheiban I, Margheri M, Vecchi G, Sangiorgi G, Santarelli A, Bartorelli A, Briguori C, Vignali L, Di Pede F, Ramondo A, Inglese L, De Carlo M, Bolognese L, Benassi A, Palmieri C, Filippone V, Sangiorgi D, De Servi S. Two-year clinical outcome with drug-eluting stents versus bare-metal stents in a real-world registry of unprotected left main coronary artery stenosis form the Italian Society of Invasive Cardiology. Am. J. Cardiol. 2008; 102: 1463-8.
47. Takaro T, Hultgren HN, Lipton MJ, Detre KM. The VA cooperative randomized study of surgery for coronary arterial occlusive disease II. Subgroup with significant left main lesions. Circulation 1976; 54(Suppl III): 107-17.